Semaglutide for Weight Loss

Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac ...  Show more

In the US, approximately 66% of reproductive-aged women have at least 1 modifiable risk factor for adverse pregnancy outcomes. Authors and ob-gyns Kylie Cooper, MD, and Daniel Breitkopf, MD, both from the Mayo Clinic, discuss ways to reduce maternal morbidity and mortality and im ...  Show more

In this episode, Johann Hari explores the complexities of obesity and weight loss drugs. He dives into the seemingly simple relationship between our food choices and innate biological responses. Reflecting on his upbringing, shaped by a diet of processed and junk food, Johann’s j ...  Show more

In today's episode of the podcast, I interview Dr. Rocio Salas-Whalen, owner of New York Endocrinology on Park Avenue. Dr. Salas-Whalen has deep expertise in diabetes, metabolism, obesity, thyroid abnormalities and other endocrine disorders. She completed her internal medicine re ...  Show more

Obesity is a physiological condition that can be managed with the right education and treatment. In today's episode, Dr. Louis J. Aronne, a leading expert in obesity research, sheds light on the science behind weight management and obesity treatment. Dr. Aronne dives into groundb ...  Show more

Despite understanding the complexities of obesity and efforts to curb obesity, rates continue to rise. Our current approach is inadequate with a siloed and mechanistic healthcare system, polarized perspectives on body acceptance and diet culture, and a lack of knowledge or acc ...